Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Kelly

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Gynecologic Oncology|April 26, 2003
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapyJ Michael Straughn, Warner K Huh, James W Orr, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Discovery of Highly Selective and Potent HDAC3 Inhibitors Based on a 2-Substituted Benzamide Zinc Binding GroupJian Liu, Younong Yu, Joseph Kelly, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
The synthesis of substituted bipiperidine amide compounds as CCR3 antagonistsPauline C Ting, Joe F Lee, Jie Wu, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2020
Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivationWensheng Yu, Jian Liu, Younong Yu, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for ClearanceJian Liu, Joseph Kelly, Wensheng Yu, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Non-aromatic A-ring replacement in the triaryl bis-sulfone CB2 receptor inhibitorsEric J Gilbert, Guowei Zhou, Michael K C Wong, et al.
Lancet (London, England)|September 17, 2021
Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trialBernadette C Young, David W Eyre, Saroj Kendrick, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2018
Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncologySobhana Babu Boga, Abdul-Basit Alhassan, Alan B Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutesJian Liu, Deodial Guiadeen, Arto Krikorian, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for OncologySobhana Babu Boga, Yongqi Deng, Liang Zhu, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Gynecologic Oncology|April 26, 2003
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapyJ Michael Straughn, Warner K Huh, James W Orr, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Discovery of Highly Selective and Potent HDAC3 Inhibitors Based on a 2-Substituted Benzamide Zinc Binding GroupJian Liu, Younong Yu, Joseph Kelly, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
The synthesis of substituted bipiperidine amide compounds as CCR3 antagonistsPauline C Ting, Joe F Lee, Jie Wu, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2020
Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivationWensheng Yu, Jian Liu, Younong Yu, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for ClearanceJian Liu, Joseph Kelly, Wensheng Yu, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Non-aromatic A-ring replacement in the triaryl bis-sulfone CB2 receptor inhibitorsEric J Gilbert, Guowei Zhou, Michael K C Wong, et al.
Lancet (London, England)|September 17, 2021
Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trialBernadette C Young, David W Eyre, Saroj Kendrick, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2018
Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncologySobhana Babu Boga, Abdul-Basit Alhassan, Alan B Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutesJian Liu, Deodial Guiadeen, Arto Krikorian, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for OncologySobhana Babu Boga, Yongqi Deng, Liang Zhu, et al.
Pageof 6